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Collecting duct cellIn epithelial tissues, adherens junctions (AJ) mediate cell–cell adhesion by using proteins called E-cadherins,
which span the plasma membrane, contact E-cadherin on other cells and connect with the actin cytoskeleton
inside the cell. Although AJ protein complexes are inserted in detergent-resistant membrane microdomains,
the inﬂuence of membrane lipid composition in the preservation of AJ structures has not been extensively
addressed. In the present work, we studied the contribution of membrane lipids to the preservation of
renal epithelial cell–cell adhesion structures. We biochemically characterized the lipid composition of mem-
branes containing AJ complexes. By using lipid membrane-affecting agents, we found that such agents in-
duced the formation of new AJ protein-containing domains of different lipid composition. By using both
biochemical approaches and ﬂuorescence microscopy we demonstrated that the membrane phospholipid
composition plays an essential role in the in vivo maintenance of AJ structures involved in cell–cell adhesion
structures in renal papillary collecting duct cells.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
The adhesion of cells to one another as well as to the extracellular
matrix is essential to the maintenance of tissue integrity. Adherens
junctions (AJs) mediate cell–cell adhesion using proteins called cad-
herins. Cadherins span the cell membrane, contacting cadherins on
other cells in a Ca+2-dependent homophilic manner and linking to
the actin cytoskeleton inside the cell [1]. In epithelial tissues,
E-cadherin is organized in a “core complex” that includes E-cadherin
itself, α-, β-, and γ-catenins, α-actinin, and vinculin. β-catenin inter-
acts directly with the cytoplasmic tail of E-cadherin and connects
E-cadherin to α-catenin, which binds F-actin. α-actinin and vinculin
are also F-actin-binding proteins that bind directly to α-catenin [1].
The integrity of this core complex is critical to the formation and/or
maintenance of stable cell–cell adhesions [2,3].
Many different cellular processes, such as migration, proliferation
and differentiation, can affect cell adhesion. These processes affect AJs
at different levels and, therefore, could be regulated by different mech-
anisms. The small GTPases Rac, Rho, and Cdc42 have been involved ins Biológicas, Facultad de Farm-
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rights reserved.cadherin-mediated adhesions [1,4]. Tyrosine phosphorylation of the
cadherin–catenin complex has also been involved in the regulation of
AJ assembly [5,6]. In contrast to the extensive documentation on the
mechanisms underlying the formation and maturation of AJs, the role
of the membrane lipidic environment in the regulation of such cell–
cell adhesion structures has been less often studied.
Cytoskeleton–lipid interactions seem to be involved in mediating
the anchorage of the cytoskeleton in the membrane bilayer as well
as in deﬁning the architecture of speciﬁc membrane areas, such as
membrane rafts [7,8]. The concept of membrane raft microdomains
was ﬁrst used more than ten years ago [9–11]. These membrane
microdomains are rich in cholesterol and sphingolipids, and are resis-
tant to solubilization by non-ionic detergents such as Triton X-100 in
cold [10,12]. Thus, after extraction of cells in detergent, insoluble rafts
can be separated from solubilized non-raft proteins and lipids for fur-
ther analysis. While raft refers to the domain in the intact membrane,
the term DRM (detergent-resistant membranes) corresponds to the
structure isolated by detergent insolubility [12]. Rafts localize in the
plasmamembrane, and can also be found in other membrane compart-
ments such as the Golgi apparatus and in the endocytic pathway
[10,13]. It has been reported that many of the molecular components
that regulate actin cytoskeleton and cell adhesion structures are associ-
ated with rafts [7,8,14,15]. Thereafter, the study of the consequences of
changes in the lipidic composition of the membrane environment—
where cell adhesion and cytoskeleton-associated proteins are an-
chored—is of relevance in a cellular context.
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tion plays a central role in the maintenance of renal papillary collect-
ing duct cell adhesion to the extracellular matrix [16]. In the present
work, we studied the role of membrane lipid composition in the
maintenance of renal papillary collecting duct cell adhesion to each
other. First, we biochemically characterized the membrane domains
where AJ protein complexes are localized in renal papillary cells and
then studied the effect of changes in the lipidic composition of such
microdomains on AJ structure and composition. By combining bio-
chemical and immunoﬂuorescence studies, we present experimental
evidence suggesting that in collecting duct cells, the speciﬁc lipidic
composition of rafts is a requisite for AJmaintenance, necessary to assure
a correct attachment of collecting duct cells to each other.
2. Materials and methods
2.1. Animals and tissue preparation
Male Wistar rats (250–300 g) were housed in a light-controlled
room with a 12:12 h light–dark cycle and allowed free access to
water and standard rat chow. All animals were handled according
to the rules for animal care and use of laboratory animals of the Uni-
versity of Buenos Aires (Reglamento para el cuidado y uso de animales
de laboratorio en la Universidad de Buenos Aires). The animal protocol
was reviewed and approved by the Comité de Ética para el Cuidado y
Uso de Animales de Laboratorio de la Facultad de Farmacia y Bioquí-
mica, Universidad de Buenos Aires (CICUAL-FFYB). Rats were killed
by decapitation, kidneys were removed, and renal papillae isolated
by scalpel and scissors dissection and sliced (0.5 mm thick) by using
a Stadie-Riggs microtome. Papillary slices were collected in ice-cold
10 mM Tris–HCl, pH 7.4, containing 140 mM NaCl, 5 mM KCl, 2 mM
MgSO4, 1 mM CaCl2 and 5.5 mM glucose (Tris-buffered saline, TBS),
and incubated at 37 °C in a metabolic shaking bath either in the ab-
sence or in the presence of membrane-affecting agents: 5 mM
methyl-β-cyclodextrin (Sigma, Saint Louis, MO, USA), 1 mM neomycin
(Sigma, Saint Louis, MO, USA), 25 μM lovastatin (Calbiochem-Merck,
Darmstadt, Germay), or 10 mM LiCl (Sigma, Saint Louis, MO, USA), for
30, 10, 120, or 120 min, respectively. Incubations were stopped on ice
and immediately homogenized in 10 vol of a solution of 0.25 M sucrose
containing 25 mM Tris–HCl, pH 7.4, 3 mM MgCl2, 2 mM EGTA, 1 mM
PMSF, 10 μg/mL aprotinin and 1 mM Na3VO4. Aliquots from the result-
ing homogenates were used to study the total level of AJ proteins. The
rest of the homogenates were successively centrifuged at 860 g for
10 min, 8000 g for 20 min, and 105,000 g for 60 min; the resultant pellet
corresponding to the microsomal fraction was used for further studies.
2.2. Detergent-resistant membrane isolation
Triton X-100 insoluble membrane fractions were obtained by the
two-step centrifugation process as previously described [17]. Brieﬂy,
microsomes were resuspended in one vol of ice-cold PBS containing
1 mM PMSF, 10 μg/mL aprotinin and 1 mMNa3VO4. Then, one volume
of 0.2% (v/v) Triton X-100 in PBS was added, mixed and incubated at
4 °C for 20 min. Samples were layered on 30% (w/v) sucrose and cen-
trifuged at 225,000 g at 4 °C for 2.5 h to remove the membranes pro-
tein–lipid complex as a pellet [17]. The supernatants were diluted by
three folds with PBS containing same protease inhibitors to make the
sucrose concentration 10% (w/v) and centrifuged at 225,000 g at 4 °C
for 2.5 h. The resulting pellet contained the Triton X-100 insoluble
membrane fraction and supernatants were considered as the soluble
membrane fraction (S fraction). Throughout this paper we termed
DRM as the 0.1% Triton X-100 insoluble membranes that sedimented
in 10% sucrose after centrifuging for 2.5 h at 225,000 g. Aliquots from
homogenates, DRM and S fractions were assayed for protein content
by the method of Lowry.2.3. Lipid analysis
Total lipids from DRM and the S fraction were obtained in the
lower chloroformic phase of the Bligh and Dyer extraction procedure
[18]. From total lipid extracts, individual phospholipids were separat-
ed and quantiﬁed as previously reported [19], and cholesterol content
determined by the method based on cholesterol-oxidase enzyme re-
action [20]. For the quantiﬁcation of phospholipids, speciﬁc areas of
the TLC plates (Merck, Darmstadt, Germany) were scraped off and
digested with 70% perchloric acid in the presence of ammonium mo-
lybdate (0.5%), for 2 h in a heating block at 180 °C. The resulting inor-
ganic phosphate was assayed with a Fiske–Subbarow reagent [21].2.4. Immunoprecipitation and Western blot analysis
For immnunoprecipitation purposes, aliquots of DRM containing
100 μg of protein of DRM were pre-cleared by incubation at 4 °C
with protein A/G Plus-Agarose (Santa Cruz, California, USA), and,
after centrifugation, supernatants were incubated at 4 °C for 1 h
with 2 μg of monoclonal antibody against β-catenin (Sigma, Saint
Louis, USA), or rabbit antibody against α-catenin (Sigma, Saint
Louis, USA). Thereafter, protein A/G Plus-Agarose was added and in-
cubated overnight at 4 °C with gentle shaking. The immunoprecipi-
tates were washed three times with HNTG buffer (20 mM Hepes pH
7.5, 150 mM NaCl, 0.1% (v/v) Triton X-100 and 10% w/v glycerol),
resuspended in Laemmli buffer and boiled for 5 min prior to Western
blot analysis. For Western blotting analysis of total homogenates,
DRM and S fractions, sample aliquots containing 20 μg proteins
were used. Proteins were resolved in 8% SDS-PAGE, and electrotrans-
ferred to polyvinylidene diﬂuoride (PVDF) membranes. After blotting,
membranes were treated with 5% nonfat milk in TBS-Tween 20 and
incubated with mouse anti-β-catenin (Sigma, Saint Louis, USA), rabbit
anti-α-catenin (Sigma, Saint Louis, USA), and rabbit anti-E-cadherin
(Santa Cruz, California, USA). Primary interaction was evidenced by
using the enhanced chemiluminescence kit (GE Healthcare—Argentina
Life Sciences, Buenos Aires, Argentina). When necessary, membranes
were stripped and reprobed with the antibody of interest and evi-
denced with avidin–biotin-peroxidase (Dako, Glostrup, Denmark) and
3,3′diaminobenzidine (Sigma, Saint Louis, USA). To control the protein
loading of samples, membranes were stained with Ponceau S. The in-
tensity of each band was estimated by optical densitometry with a
Gel-Pro Analyzer version 3.1 (Media Cybernetics, USA).2.5. Cell cultures and treatments with lipid-affecting agents
Primary cultures of papillary collecting duct cells were performed
according to Stokes et al. [22]. Brieﬂy, renal papillae were minced to
1–2 mm3 pieces and incubated at 37 °C in sterile TBS containing
0.1% collagenase II (Sigma, Saint Louis, USA) under 95%O2/5%CO2.
After 40 min, digestion was stopped and isolated cells and structures
were separated by centrifuging at 175 g for 10 min. The crude pellet
containing most papillary cell types, tubular structures and tissue de-
bris was washed twice and resuspended in Dulbecco's modiﬁed
Eagle's medium (DMEM) with F-12 (1:1) (GIBCO, Invitrogen, California,
USA), 10% fetal bovine serum (FBS) (Natocor, Córdoba, Argentina),
100 U/ml penicillin and 100 μg/ml streptomycin (GIBCO, Invitrogen,
California, USA). The enriched collecting duct pellets were obtained by
centrifugation at 60 g for 1 min and resuspended in an adequate volume
of DMEM/F12. Enriched-tubular suspensions were seeded in sterile dry-
glass coverslips placed in six-well multidishes. After growing at 37 °C
for 96 h, cultures were treated with either 5 mM methyl-β-cyclodextrin
for 30 min, 10 mM neomycin for 10 min, 25 μM lovastatin, or 10 mM
LiCl for 24 h. Incubations were stopped on ice and then the coverslips
were transferred to cold PBS.
Fig. 1. Biochemical protein characterization of DRMs from renal papillary cells. DRM and
Triton-soluble fractions (S) were obtained from renal papillae as described in Materials
and methods, and equivalent amounts of protein were resolved by electrophoresis and
immunoblotted for E-cadherin, β-catenin and α-catenin (A). DRM was immunoprecipi-
tated (IP) for β-catenin (B), and for α-catenin (C) and then immunoblotted (IB) with
the indicated antibody.Minus (−) indicates samples of DRMwhichwerenot immunupre-
cipitated with the indicated antibody. Results correspond to a representative experiment
of three individual assays.
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For immunostaining, cultured cells treated with methyl-β-
cyclodextrin, neomycin, lovastatin or LiCl, as described above, were
ﬁxed with methanol (at −20 °C for 10 min) and acetone (at −20 °C
for 4 min), and blocked with 3% goat normal serum (Vector Laborato-
ries, California, USA) in PBS. Then, cells were incubated with the ap-
propriate combinations of antibodies overnight at 4 °C in goat
serum containing PBS. The following primary antibodies were used:
mouse anti-β-catenin (Sigma, Saint Louis, USA), rabbit anti-α-
catenin (Sigma, Saint Louis, USA), rabbit anti-E-cadherin (Santa
Cruz, California, USA). Mouse and rabbit primary antibodies were
detected using ﬂuorescent Alexa Fluor 488 or 546 conjugated F(ab)2
fragment goat anti-mouse or anti-rabbit (Molecular Probes). Finally,
the cells were mounted using Vectashield Mounting Media (Vector
Laboratories, California, USA) and stored at 4 °C until analysis. Speci-
mens were examined with an Olympus FV300 Confocal Microscope
(Model BX61), with an acquisition software FluoView version 3.3
provided by the manufacturer. Double ﬂuorescence for green and
red channels was visualized by using an argon–helium–neon laser.
Double-stained images were obtained by sequential scanning for each
channel to eliminate the crosstalk of chromophores. Analysis of the con-
focal images and the colocalizationwas performedwith the image anal-
ysis software Image-Pro Plus version 5.1.2 (Media Cybernetics, USA).
Cell morphology was assessed by F-actin staining with FITC-coupled
phalloidin (Sigma, Saint Louis, USA) and by phase-contrast microscopy
using an Olympus inverted microscope with an X40 objective. All im-
ageswere obtainedwith a cooled CCD camera and processed for output
purposes using Adobe Photoshop software.
2.7. Statistic
Results are expressed as mean±SE. We used the unpaired t-test
for comparison between DRM and S fractions, and between data
from control and different treatments (Pb0.05).
3. Results
3.1. Adherens junction proteins are localized in rafts microdomains in renal
papillary collecting duct cells
To determine whether the AJ components E-cadherin, β-catenin,
and α-catenin are part of DRM, we analyzed Triton X-100-resistant
and soluble fractions obtained from the microsomal fraction of rat
renal papillary collecting duct cells. DRM isolated in our experimental
conditions probably represents a mix of various lipid rafts in the renal
papillary collecting duct cells, of which only a part constitutes the AJ
membrane domains. Immunoblot analysis of DRM and the soluble
fraction showed bands corresponding to the molecular weight of E-
cadherin (~125 KDa), α-catenin (~105 KDa) and β-catenin (~94 KDa).
In the soluble fraction, no E-cadherin and α-catenin bands were
detected, whereas a band corresponding to the molecular weight of
β-catenin (~94 KDa) was observed (Fig. 1A).
In organized simple epithelia, like in collecting ducts, adherens
junction E-cadherin is associated with catenins in the cytoplasmic do-
main, where they form a multiprotein complex in the sequence of
cadherin to β-catenin, and β-catenin to α-catenin [1]. To verify
whether such organized complex is present in the DRMmicrodomain,
we performed an immunoprecipitation with anti-β-catenin and the
presence of E-cadherin was analyzed in the precipitate. In separate
samples, an immunoprecipitation with anti-α-catenin was performed
and the presence of β-catenin was analyzed in the precipitate. As seen
in Figs. 1B and C, E-cadherin was efﬁciently immunoprecipitated with
anti-β-catenin, and β-catenin was immunoprecipitated with anti-
α-catenin. The percentage of isolated E-cadherin immunoprecipitated
by anti-β-catenin was of 57% while the percentage of β-cateninimmunoprecipitated by anti-α-catenin was of 17% The fact that
β-catenin was found bound to E-cadherin, and that α-catenin co-
immunoprecipitated with β-catenin in Triton X-100 insoluble fraction
denotes that AJ complexes are present in rafts microdomains in renal
papillary collecting duct cells. It is interesting to note that the ratios be-
tween upper and lower bands in the immunoblot of E-cadherin before
and after the immunoprecipitation with anti-β-catenin are different. It
could be due to the presence of a calpanin induced E-cadherin fragment
which is recognizable by the E-cadherin antibody but has lower afﬁnity
to bind β-catenin.
We further characterized the lipid composition of DRM in compar-
ison with the Triton X-100 soluble (S) fraction, by determining the
cholesterol and sphingomyelin (CerPCho) content, as well as the
phospholipid proﬁle. Typical of DRM, cholesterol and CerPCho con-
centration were higher in the insoluble than in the S fraction
(Fig. 2A). With respect to the phospholipid proﬁle, DRM showed a 30%
increase in phosphatidylethanolamine (PtdEtn) and a 40% decrease in
phosphatidylserine (PtdSer), with no differences in phosphatidylcholine
(PtdCho) and phosphatidylinositol (PtdIns) concentrations (Fig. 2A). It is
known that polyphosphoinositides play a central role in interacting with
cytoskeleton proteins, thus regulating actin cytoskeleton dynamics [23].
The amounts of DRM-polyphosphoinositides, phosphatidylinositol-4-
phosphate (PtdIns(4)P) and phosphatidylinositol-4,5-bisphosphate
(PtdIns(4,5)P2), were several times higher than in the S fraction, denot-
ing the massive accumulation of these acidic phospholipids in DRM
(Fig. 2B). Altogether, these results demonstrate that in renal papillary
collecting duct cells, AJ complexes are located in cholesterol–sphingo-
myelin–polyphosphoinositide-enriched membrane domains.
3.2. The persistence of AJ depends on membrane lipid composition
In order to study the importance of DRM lipid composition in the
maintenance of the AJ complex, we treated renal papillary slices with
the membrane-affecting agents methyl-β-cyclodextrin (CD), neomy-
cin (Neo) and LiCl. We ﬁrst checked changes in the lipid composition
of the Triton insoluble fraction and thereafter we biochemically studied
the presence of the AJ complex.We also evaluatedwhether the different
treatments altered the total protein level in the DRM fraction isolated
from the microsomal fraction.
Fig. 2. Lipid characterization of DRM (black) and S fractions (white). Endogenous content of cholesterol, individual phospholipids (A), and polyphosphoinositides (B) was deter-
mined on DRM and S fraction aliquots, according to the methodology described for each kind of molecule. (Mean±SE, n=5). *Signiﬁcantly different from S, pb0.05. PLs,
phospholipids.
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selectively extracts cholesterol from the membrane without affecting
the viability of living cells [24], decreased cholesterol content by 35%,
but also caused an overall change in the phospholipid proﬁle. The most
signiﬁcant change in the phospholipid proﬁle was the 100% and 50% in-
crease observed in CerPCho and PtdIns concentrations respectively, and
the 30% decrease in PtdEtn content, while PtdIns(4)P and PtdIns(4,5)P2
did not change signiﬁcantly (Fig. 3A). Neo, a known PtdIns(4,5)P2Fig. 3. Lipid composition and protein content of DRM after treatment with membrane-affec
neomycin, or (C) 10 mMLiCl, and DRMwere isolated. Variation in cholesterol, individual phosp
DRM protein content per mg of renal papilla tissue slices treated with 5 mM cyclodextrin (CDsequestering agent [25], caused an unexpected 60% decrease in choles-
terol concentration, accompanied by a slight decrease (10%) in CerPCho
content (Fig. 3B). Neo also increased PtdIns(4,5)P2 by 65% while
PtdIns(4)P concentration decreased about 10% (Fig. 3B). The treatment
with LiCl, which blocks phosphoinositide synthesis [26], evoked an in-
crease in cholesterol and CerPCho content by 35% and 25%, respec-
tively, accompanied by a decrease in PtdCho, and an important PtdIns
and PtdSer enrichment. No changes in PtdEtn content were observed.ting agents. Renal papillary slices were treated with (A) 5 mM cyclodextrin, (B) 1 mM
holipids, and polyphosphoinositides is expressed as percentage of control. (D) Variation in
ex) , 1 mM neomycin (Neo), or 10 mM LiCl (Mean±SE, n=5).
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ing for a 50% and 25% decrease, respectively (Fig. 3C). Respect to the
total protein level in the DRM fraction, no signiﬁcant changes were ob-
served (Fig. 3D).No changes in lipid composition of total cellular mem-
brane were observed after the treatment with the various drugs (data
not shown).
Taken together, the results demonstrate that the various mem-
brane lipid-affecting agents caused a redistribution of membrane
lipids, bringing about the formation of modiﬁed domains of different
lipid composition, but did not alter the total DRM protein level.
Thereafter, we studied the presence of epithelial cell–cell adhesion
proteins in total homogenates and in DRM isolated from microsomal
fraction either treated or not with the different lipid-affecting agents
by immunoblotting.
CD caused a slight decrease in DRM–E-cadherin content, whereas
Neo caused a 50% decrease (Fig. 4A). The level of E-cadherin in total
homogenate was signiﬁcantly altered after CD treatment, whereas no
signiﬁcant changes were observed after Neo and LiCl treatments
(Fig. 5A). These results demonstrate that despite the decrease in total
amount of E-cadherin induced by CD, the protein persists in the modi-
ﬁed DRM. By contrast, Neo affected mainly the DRM–E-cadherin while
the total amount decreased by only 20%. On the other hand, the total
level as well as the DRM content of the protein was resistant to LiCl
treatment (Figs. 4A and 5A).Fig. 4. Effect of changes in DRM lipid composition on the amount of E-cadherin (A), β-caten
Materials and methods, and equal amounts of total protein were developed in an 8% SDS-PA
Ponceau S. (Mean±SE, n=3). Representative immunoblots are shown. *Signiﬁcantly differ
α-catenin and then immunoblotted (IB) with the indicated antibody. Results correspond toβ-Catenin–DRM was profoundly affected by CD and Neo, showing
50% and 70% decrease in its content respectively, whereas no changes
were observed by the treatment with LiCl (Fig. 4B). No signiﬁcant
changes in the amount of β-catenin were observed after any treat-
ment in total homogenate (Fig. 5B). Consequently the low level of
β-catenin in DRMwas not due to the decrease in total level but to dis-
sipation from DRM.
All three agents affected DRM–α-catenin content, since a 40% de-
crease was observed after CD and Neo treatments and a 20% decrease
was observed after LiCl treatment (Fig. 4C). In total homogenate, CD
and Neo did not signiﬁcantly alter the total level of α-catenin, whereas
LiCl caused a 25% decrease in its content (Fig. 5C). These results may in-
dicate that while CD and Neo speciﬁcally dissipated α-catenin from
DRM, the decrease induced by LiCl could be due to the decrease in
total content.
E-cadherin forms complexes with catenins, which in turn, func-
tionally link E-cadherin to the actin cytoskeleton [1]. Changes in the
composition of the AJ complexes, and alterations in their interaction
with the cytoskeleton have been suggested to play a key role in the
regulation of cell–cell adhesion [2]. To analyze whether changes in
the lipid composition of DRM affects the composition of the AJ com-
plexes, we performed immunoprecipitation experiments to analyze
the association of β-catenin with E-cadherin, as well as that of β-
catenin with α-catenin. The immunoblot analysis showed a lowerin (B) and α-catenin (C). DRM from microsome samples were obtained as described in
GE and analyzed by Western blotting. Protein loading was controlled by staining with
ent from control, pb0.05. (D) DRM were immunoprecipitated (IP) for β-catenin, or for
a representative experiment of three individual assays.
Fig. 5. Analysis of the total level of (A) E-cadherin, (B) β-catenin, and (C) α-catenin in renal papilla homogenates. Renal papillary slices were treated with 5 mM cyclodextrin
(CDex), 1 mM neomycin (Neo), or 10 mM LiCl, and homogenate samples were obtained. Equal amounts of total protein were developed in an 8% SDS-PAGE and analyzed by Western
blotting. Representative immunoblots are shown. (Mean±SE, n=3). *Signiﬁcantly different from control, pb0.05.
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ted with CD, Neo or LiCl, when a speciﬁc antibody anti-β-catenin was
used (Fig. 4D). The amount of α-catenin that co-immunoprecipitated
with β-catenin after CD and LiCl did not change, whereas the band
obtained after Neo treatment increased (Fig. 4D). Similar results were
obtained with β-catenin when the immunoprecipitation was per-
formed with an anti-α-catenin antibody (Fig. 4D).
Since cholesterol is known to play an important role in lipid rafts,
we further investigated whether the inhibition of cholesterol synthesis
affected AJ proteins. To this end, we performed incubation with 25 μM
lovastatin (Lova), an inhibitor of 3-hydroxy-3-methylglutaryl-CoA re-
ductase, for 2 h. This treatment profoundly affected DRM–AJ protein as-
sociation, since E-cadherin contents decreased by 70%, and β- and
α-catenin contents decreased by 50% (Fig. 6A), but no change in the
total protein level in DRM after lovastatin was observed (DRM protein
content (μg/mg tissue) Control: 3.81±0.66 vs Lovastatin: 3.71±0.81,
pNS). In total homogenates, the decrease in E-cadherin and α-catenin
accounted only for 25%, and no decrease was observed for β-catenin
(Fig. 6B).
Taken together, the results demonstrate that the various mem-
brane lipid-affecting agents differently disturbed the interaction of
the AJ proteins in DRM, thus causing a decreased assemblage of the
AJ protein complexes.
3.3. AJ integrity depends on membrane lipid composition
In order to obtain a morphological correlation of the biochemical
ﬁndings, we performed primary cultures of renal collecting ductFig. 6. Effect of lovastatin on the amount of E-cadherin, β-catenin and α-catenin content in (
with 25 μM lovastatin. DRM or homogenates were obtained as described in Materials and
analyzed by Western blotting. Representative immunoblots are shown. (Mean±SE, n=3)cells and studied the effect of the membrane-affecting agents on AJ
integrity. The ﬁxed cultured cells were stained with anti-E-cadherin,
anti-β-catenin, and anti-α-catenin. The protein distribution was visu-
alized with confocal microscopy. In untreated cells, the phase contrast
micrograph shows the typical morphology of cultured collecting duct
cell displaying a well spread morphology (Fig. 7A). As shown in FITC-
phalloidin stained cells, actin appeared organized as stress ﬁbers and
also as cortical network showing a correct cell organization of primary
cultured cells, resembling tissue conformation (Fig. 7B). Within 30 min
of CD treatment, the cellsweremore dispersed (Fig. 7C), and thephalloi-
din immunoﬂuorescence showed disorganization of cell cultures, with
loss of the epithelial morphology (Fig. 7D). In the center of the colony,
cells appeared retracted and rounded, with the presence of cortical
actin-based structures (Fig. 7D, arrowhead). Neo treatment caused a
complete disintegration of cell–cell adhesion and a large percentage of
cells appeared isolated (Fig. 7E). The phalloidin signal shows a colony
in a process of disorganization (Fig. 7F). The loss of epithelial morpholo-
gy, resembling that of themigrating cell, is clearly seen in a cell of thepe-
riphery of the colony (Fig. 7F, arrowhead). In LiCl-treated cells, the
phalloidin images show an increased number of short stress ﬁbers
(Fig. 7H). The preservation of the actin organization in stress ﬁbers can
explain themaintenance of the cellularmorphology (Fig. 7G). Lovastatin
treatment caused a dissipation of cell–cell adhesions, the cells looked
more dispersed (Fig. 7I), and, as shown in the phalloidin immunoﬂuo-
rescence, a great percentage of cells lost the epithelial morphology
(Fig. 7J). It is accepted that the integrity of the AJ complexes is critical
to themaintenance of stable adhesions [3]. To analyze whether changes
in the lipid composition of DRMaffect the interaction of theseproteins atA) DRM and in (B) homogenates from renal papilla. Renal papillary slices were treated
methods, and equal amounts of total protein were developed in an 8% SDS-PAGE and
. *Signiﬁcantly different from control, pb0.05.
Fig. 7. Effect of lipid-affecting agents on themorphology and actin cytoskeleton of cultured
collecting duct cells. Cultured collecting duct cellswere treatedwith 5 mMcyclodextrin (C,
D), 1 mM neomycin (E,F), 10 mM LiCl (G,H), or 25 μM lovastatin (I,J). After ﬁxation, cells
were observed with a phase-contrast microscope, or immunostained with FITC-
phalloidin and observed with a confocal microscopy, and sections crossing the cell–cell
contacts are shown. Representative images of three independent experiments are shown.
Scale bars: 50 μm.
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tures performing immunoﬂuorescence microscopy using E-cadherin,
β-, and α-catenin antibodies. We ﬁrst studied E-cadherin and
β-catenin distribution. The colocalization of AJ proteins was analyzed
by using the Image Pro colocalization module. In untreated cells,E-cadherin as well as β-catenin lined the lateral membrane, and coloca-
lized at the cell–cell contacts, thus reﬂecting the presence of AJ struc-
tures (Figs. 8A and B), as assessed in the segmentation images where
colocalization appearedwhite (Fig. 8C). This is better observed in the en-
larged ﬁgure inserts of cell–cell adhesion regions (Fig. 8C, insert). By
contrast to the high degree of E-cadherin–β-catenin colocalization in
untreated cells, each of the membrane-affecting agents induced an al-
most complete disappearance of colocalization between these proteins
at cell–cell junctions, as seen in the representative segmentation images.
After 30 min of CD treatment, the cell contacts appeared disintegrated
and most of the E-cadherin dissipated from the lateral membrane
(Fig. 8D), and appeared massively internalized as E-cadherin-containing
vesicle-like structures that did not contain β-catenin (Fig. 8F, insert). By
contrast, the β-catenin-positive signal is peripheric (Fig. 8F, insert) and
presents β-catenin-positive but E-cadherin-negative bridges between
adjacent cells (Fig. 8F, arrowhead). Neo treatment caused evenmore pro-
found alterations, since cells were completely separated. Although
E-cadherin as well as β-catenin distributed in the periphery of the cell,
they did not form AJs (Figs. 8G and H). In a complete isolated cell,
E-cadherin appeared delocalized from the plasmamembrane and inten-
sively accumulated in the cytosol (Fig. 8G, arrowhead).β-catenin distri-
bution was similar to that observed for E-cadherin, with accumulation
in certain zones of the cell (Fig. 8H, arrowhead). In non-rounded cells,
although both E-cadherin and β-catenin were peripherically distribut-
ed, they did not colocalize, since only scarce points of overlapping
were observed (Fig. 8I). In an isolated rounded cell, internalized
vesicle-like structures were observed. Some were E-cadherin- and
others β-catenin-positive, whereas only a few of them presented over-
lapping (Fig. 8I, insert). Interestingly, large β-catenin-positive and short
E-cadherin-positive ﬁlopodia-like structures that did not overlap were
also present (Fig. 8I, arrowhead). The different cell shape observed in
the image Figs. 8G, H and I could reﬂect different stages of Neo deleteri-
ous effect. In LiCl-treated cells, no overlapping between AJ proteins was
observed (Fig. 8L). Under LiCl treatment, cells still appeared spread but
lost their cell–cell adhesion, conserving some β-catenin-stained bridges
of connections between cells (Fig. 8K, arrowhead). While β-catenin still
remained lining the cell periphery, E-cadherin was completely internal-
ized, showing a punctuated pattern of distribution (Fig. 8J). In the mag-
niﬁed image (Fig. 8L, insert), it can be observed that cell connecting
bridges are β-catenin- and E-cadherin-stained but appear as separated
entities that did not colocalize. Lovastatin caused a massive E-cadherin
internalization, with complete dissipation fromplasmamembrane local-
ization, acquiring a punctuated pattern of distribution (Fig. 8M). By con-
trast, β-catenin still remained lining the cell, conserving some segments
of cell–cell adhesion, butmost of the cells are in the process of separation.
In the magniﬁed image of part of the cells, it can be observed that
β-catenin is lining the periphery andE-cadherin as vesicle-like structures
which did not contain β-catenin (Fig. 8O, insert).
Since besides interacting with the cytoplasmic domain of
E-cadherin, β-catenin binds intracellular α-catenin to conform AJ,
we further studied the β- and α-catenin distribution and their relation-
ship (Fig. 9). In control, untreated cell cultures, β- and α-catenin had al-
most the same pattern of distribution, with a high degree of
colocalization in the plasma membrane (Figs. 9A, B and C). After CD
treatment, β-catenin as well as α-catenin mostly occupied the cell pe-
riphery, presenting zones of protein accumulation (Figs. 9D and E, ar-
rowheads). Cell–cell adhesion was impaired and most of the cells
started to separate. Some long bridges connected the cells and in the
magniﬁed image of a bridge it is possible to observe that both β- and
α-catenin staining is present (Fig. 9F, insert). The images of β- and
α-catenin colocalization show that although both proteins colocalized
partially, cell–cell adhesion was not conserved (Fig. 9F). Neo caused the
delocalization of both β- and α-catenins from the plasma membrane
(Figs. 9G and H), but a thin line of non-interacting β- and α-catenins
retained the rounded cells interconnected (Fig. 9I, arrowhead). Two
polarized population of vesicles were also observed. One pole appears
Fig. 8. Effect of changes in DRM lipid composition in the interaction of AJ proteins. Cultured collecting duct cells were treated with 5 mM cyclodextrin (CDex), 1 mM neomycin
(Neo), 10 mM LiCl, or 25 μM lovastatin. After ﬁxation, cells were simultaneously immunostained with antibodies against E-cadherin (green) and β-catenin (red). The colocalization
study between E-cadherin and β-catenin was performed using the Image Pro colocalization module. Confocal sections crossing the cell–cell contacts are shown. Representative im-
ages of three independent experiments are shown. Scale bar: 20 μm.
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pears enriched in β-catenin-positive vesicles (Fig. 9I, insert). After LiCl
treatment, both β- and α-catenin remained partially in the periphery
of the cells (Figs. 9J and K) but also an intracellular punctuate labeling
pattern was also observed, denoting some protein internalization
to peripheral organelles (Figs. 9J and K). Interestingly, despite thesimilar β- and α-catenin distribution, the detailed observation of
the merged images shows that α-catenin appeared more externally lo-
calized than β-catenin (Fig. 9L, arrowhead), which justiﬁed the difﬁcult
cell–cell adhesion. By contrast, in the portion of the cell membrane
where cell–cell adhesion persisted, β- and α-catenin colocalized
(Fig. 9L, insert), as assessed in the segmentation image. Lovastatin
Fig. 9. Effect of changes in DRM lipid composition on the interaction of AJ proteins Cultured collecting duct cells were treated with 5 mM cyclodextrin (CDex), 1 mM neomycin (Neo),
10 mM LiCl, or 25 μM lovastatin. After ﬁxation, cells were simultaneously immunostained with antibodies against β-catenin (green) and α-catenin (red). The colocalization study be-
tween β-catenin and α-catenin was performed using the Image Pro colocalization module. Confocal sections crossing the cell–cell contacts are shown. Representative images of three
independent experiments are shown. Scale bar: 20 μm.
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intracellular distribution. However, there are some zones of the mem-
brane where both catenins persisted and colocalized maintaining zones
of cell–cell adhesion (Fig. 9O, insert). By contrast, some internalized
vesicle-like structures are β-catenin and others are α-catenin-positive.4. Discussion
In the present work, we studied the importance of membrane lipid
composition in the maintenance of E-cadherin-mediated cell–cell ad-
hesion. To this end, we took advantage of the fact that cultured
500 M.G. Márquez et al. / Biochimica et Biophysica Acta 1818 (2012) 491–501papillary collecting duct cells preserve their tendency to interact with
their neighboring cells, mimicking their behavior in intact tissue.
Therefore, we established a parallelism between the biochemical
data obtained from renal papillary collecting duct microsomes and
the morphological observations from immunoﬂuorescence microscopy
performed in primary cultures of collecting duct cells. By combining
biochemical and immunoﬂuorescence studies, we demonstrated that
the membrane lipid composition affects the in vivo preservation of AJ.
We ﬁrst demonstrated that the AJ complexes were present in
DRM. It has been demonstrated that the DRM composition critically
depends on the cell type, the starting material and the isolation pro-
tocols [27]. For this reason, we analyzed the lipid composition of the
isolated DRM and found that they had the biochemical characteristics
of lipid rafts. Besides the enrichment in cholesterol and sphingomye-
lin, the isolated DRM are also enriched in PtdIns(4)P and PtdIns(4,5)
P2, consistent with the earlier observation of Hope and Pike [28]. In
accordance with our results, previous studies performed in MDCK
cells [14], a cell line of dog kidney collecting ducts, and in murine ﬁ-
broblasts [29] have shown the association of the AJ proteins with
the Triton X-100 insoluble fraction. More recently, immunoﬂuores-
cence and biochemical experiments demonstrated that N-cadherin
of AJ colocalized with lipid rafts in C2C12 myoblasts [30]. In our opin-
ion, the above ﬁndings highlight the relevance of rafts as membrane
platforms where cadherin-mediated cell adhesions are located. It
has been proposed that because of their relative stability and complex-
ity, cell–cell junctions can be considered membrane microdomains
themselves [15]. In the present work, we used various membrane-
affecting agents as tools to study the inﬂuence of the membrane lipid
composition on AJ preservation. We showed that such agents affected
the AJ components differently, depending on their capacity to change
themembrane lipid composition. In accordance with previous observa-
tions in smooth muscle cells [31], cyclodextrin did not lead to raft elim-
ination. Instead, here we showed that besides inducing a cholesterol
decrease, cyclodextrin caused membrane lipid redistribution, leading
to a modiﬁed microdomain with lower cholesterol but higher sphingo-
myelin content. With respect to cell–cell adhesion, the immunoﬂuores-
cence images show that cyclodextrin caused an almost complete
separation of collecting duct cells. This fact, which is not compatible
with epithelial tissue preservation, seems to be due to an impairment
of E-cadherin span in the membrane domain of new lipid composition.
It appears that in such environment E-cadherin internalized rather than
stayed in the plasmamembrane. As E-cadherin internalized, AJ dissipat-
ed. Dissipation of AJ is consistent with the decrease in AJ complexes in
DRM, which is also supported by the decreased content of β- and
α-catenins as observed by inmunoblotting. However, DRM–E-cadherin
was not very signiﬁcantly lower in CD-treated than in control DRM, pos-
sibly due to vesicular E-cadherin that co-sedimented with membrane
DRM during the process of isolation. Thus, we suggest that CD induces
modiﬁcations in the lipid composition, creating a different lipid envi-
ronment where E-cadherin internalizes and where β- and α-catenins
are excluded, thus causing AJ dissipation.
Neomycin appeared as themost deleterious agent, as denoted in the
phalloidin-stained images. Consistently, AJ proteins dissipated from
DRM, as observed by immunoblotting. The signiﬁcant decrease in cho-
lesterol, together with the absence of the counterbalance increase in
sphingomyelin, may cause an extremely non-favorable lipid domain
for the AJ proteins. It is known that cholesterol has high afﬁnity for
sphingomyelin and probably the decrease of cholesterol is secondary
to the sphingomyelin fall. Interestingly, although in lower amounts,
E-cadherin persisted in the plasmamembrane, and partially colocalized
with β-catenin, whereas α-catenin appeared as the most affected AJ
protein. Recently, Weiss and Nelson [32] have reported that the
α-catenin interaction with β-catenin and that with the actin ﬁlament
exclude mutually. Interestingly, we here showed that, although AJ com-
plexes were impaired by Neo, an increase in the amount of α-catenin
bound to β-catenin was obtained. Such an increase in the β-catenin–α-catenin interaction may affect the interaction of the latter with actin
ﬁlaments. Thus, the action of Neo appeared dividing β-catenin in two
pools: one that persists bound to E-cadherin and the other that is pulled
in by α-catenin. Probably, by increasing the interaction between
β-catenin and α-catenin, the α-catenin–actin ﬁlament binding dimin-
ishes, thus producing the overall alteration of the epithelial cell
morphology.
Taking into account that cultured cellswere treatedwith cyclodextrin
and neomycin for a short period of time (30 and 10 min, respectively), it
is evident that the membrane domains where AJ complexes are located
are highly sensitive to the effect of such agents. Similar results were
obtained when cells were treated with lovastatin, an inhibitor of 3-
hydroxy-3-methylglutaryl-CoA reductase that decreases intracellular
cholesterol concentration, thus corroborating that cholesterol is crucial
to maintain AJ structure.
LiCl also caused the impairment of AJ. E-cadherin internalized
whereas β and α-catenins persisted in the plasma membrane. Al-
though both β- and α-catenins remained localized in the plasma
membrane, they did not colocalize. Consistently, the treatment with
LiCl is the condition where less α-catenin associates with β-catenin,
as is seen in the immunoblot. Both ﬁndings reﬂected failure in the in-
teraction between β- and α-catenin. Interestingly, LiCl caused the ap-
pearance of a huge number of stress ﬁbers which is consistent with
our previous observation that LiCl induces an increase of talin con-
taining focal adhesions [16]. LiCl caused no loss of cholesterol and
sphingomyelin but changed the relative proportion of neutral and
acidic phospholipids, and in such environment AJ were impaired.
Thereafter, it is evident that the maintenance of the overall lipid com-
position of AJ domains is critical to maintain the integrity of AJ. These
results allow us to hypothesize that transient, physiological changes
in the phospholipid proﬁle of AJ domains might physiologically modu-
late AJ turnover. We consider that the various agents used change spe-
ciﬁcally the lipid composition of DRM fraction because in DRM are
concentrated the phospholipid hydrolysing enzymes and also the phos-
phoinositides kinases thus regulating the local lipid composition. It is
accepted that membrane sphingomyelin is an endogenous inhibitor of
phospholipases. We consider that the changes in sphingomyelin con-
tent can induce the activation of local phospholipases, thus affecting
the local concentration of phospholipids.
It is accepted that the continuous expression and functional activ-
ity of E-cadherin are required for cells to remain tightly associated in
the epithelium, and that, in their absence; the other cell-adhesion
proteins are not capable of supporting intercellular adhesions [33].
Both during tumorigenesis and normal development, epithelial cells
lose intercellular adhesions. This has been attributed to low levels
or absence of E-cadherin expression [33,34]. Here we report loss of
AJ caused by modiﬁcation of the lipid membrane environment
where cell-adhesion proteins assemble to form AJ complexes. This
work constitutes the ﬁrst report of cell–cell adhesion impairment
due to changes in their lipid environment.
It is interest to point out that both neomycin and LiCl are pharma-
cological agents of known nephrotoxic effects. In this context, our re-
sults could also be pharmacologically relevant. Neomycin is an
aminoglycoside antibiotic known to cause tubular necrosis [35,36].
Here we showed that a short period of neomycin treatment is able
to destroy cell–cell adhesions. The disruption of cell–cell adhesions
could explain the deleterious effect caused by neomycin treatment.
Regarding LiCl, it is chronically used for treatment of some human
mental diseases [37,38] and it is known that long-term treatment
with this agent causes alterations in the renal capacity for concentrating
urine [39]. It is known that the papillary collecting duct is in fact the
structure where the ﬁnal adjustment of urine volume occurs. Although
the pharmacological dose of LiCl is lower (0.8–1 mM) than the concen-
tration used here, we hypothesize that chronic low doses of LiCl could
also impair cell–cell adhesion and thus affect renal function. Lovastatin
is used as a pharmacological agent to treat hypercholesterolemia.
501M.G. Márquez et al. / Biochimica et Biophysica Acta 1818 (2012) 491–501Although, to our knowledge, no nephrotoxic effect has been reported,
our results suggest the possibility that it can induce deleterious effects
on epithelial renal tissues.
In the present report we present evidence on the involvement of
the lipid membrane composition in AJ integrity and suggest that the
DRM isolated in our experimental conditions is a submicrodomain
that serves as a platform to localize AJ components and that behaves
as a biochemical unit facilitating the correct interaction of cell–cell
adhesion components. In addition, we propose that the maintenance
of the physiological lipid composition of DRM is a requisite to pre-
serve cell–cell adhesion and consequently the collecting duct tubular
organization and its functionality.5. Conclusions
We used various membrane-affecting agents as tools to study the in-
ﬂuence of themembrane lipid composition onAJ preservation on collect-
ing duct cells. Methyl-β-cyclodextrin does not lead to raft elimination.
Instead, provokesmembrane lipid redistribution, leading to a newmem-
brane domainwith lower cholesterol but higher sphingomyelin content.
In such environment E-cadherin internalizes, and β- and α-catenins are
excluded, thus causing AJ dissipation. Neomycin induce a decrease in
cholesterol with the absence of the counterbalance increase of sphingo-
myelin, causing an extremely non-favorable lipid domain for the AJ pro-
teins as denoted by the loss of cell–cell adhesion and the alteration of the
epithelial cell morphology. The decrease in cholesterol is a common fea-
ture in the deleterious effect of cyclodextrin and neomycin.We thus sug-
gest that cholesterol is crucial for bringing out the lipid environment
necessary tomaintain the AJ complexes assembled. The use of lovastatin,
another cholesterol modiﬁer agent, corroborates this statement. LiCl
causes no loss of cholesterol and sphingomyelin but changes the relative
proportion of neutral and acidic phospholipids, and in such environment
AJs are impaired. The maintenance of the overall lipid composition of AJ
domains is critical to maintain the integrity of AJs. These results allow us
to hypothesize that transient, physiological changes in the phospholipid
proﬁle of AJ domains might physiologically modulate AJ turnover. This
work constitutes the ﬁrst report of cell–cell adhesion impairment due
to changes in their lipid environment. It is interest to point out that
both neomycin and LiCl are pharmacological agents of known nephro-
toxic effects. In this context, our results could also be pharmacologically
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